Report Detail
Global Sodium Valproate Market Insights, Forecast to 2025
- RnM3521236 |
- 14 June, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
Valproate (VPA), and its valproic acid, sodium valproate, and valproate semisodium forms, are medications primarily used to treat epilepsy and bipolar disorder and to prevent migraine headaches. It is useful for the prevention of seizures in those with absence seizures, partial seizures, and generalized seizures.
The global Sodium Valproate market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Sodium Valproate market based on company, product type, end user and key regions.
This report studies the global market size of Sodium Valproate in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Sodium Valproate in these regions.
This research report categorizes the global Sodium Valproate market by top players/brands, region, type and end user. This report also studies the global Sodium Valproate market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
sanofi-aventis
AbbVie
Athenex
Fresenius Kabi
Hikma Farmaceutica
Desitin Pharmaceuticals
Wockhardt
Zentiva
Market size by Product
Injection
Tablet
Liquid
Market size by End User
Epilepsy
Migraines
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Sodium Valproate market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Sodium Valproate market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Sodium Valproate companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Sodium Valproate submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Sodium Valproate are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Sodium Valproate market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Sodium Valproate Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Sodium Valproate Market Size Growth Rate by Product
- 1.4.2 Injection
- 1.4.3 Tablet
- 1.4.4 Liquid
- 1.5 Market by End User
- 1.5.1 Global Sodium Valproate Market Size Growth Rate by End User
- 1.5.2 Epilepsy
- 1.5.3 Migraines
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Sodium Valproate Market Size
- 2.1.1 Global Sodium Valproate Revenue 2014-2025
- 2.1.2 Global Sodium Valproate Sales 2014-2025
- 2.2 Sodium Valproate Growth Rate by Regions
- 2.2.1 Global Sodium Valproate Sales by Regions
- 2.2.2 Global Sodium Valproate Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Sodium Valproate Sales by Manufacturers
- 3.1.1 Sodium Valproate Sales by Manufacturers
- 3.1.2 Sodium Valproate Sales Market Share by Manufacturers
- 3.1.3 Global Sodium Valproate Market Concentration Ratio (CR5 and HHI)
- 3.2 Sodium Valproate Revenue by Manufacturers
- 3.2.1 Sodium Valproate Revenue by Manufacturers (2014-2019)
- 3.2.2 Sodium Valproate Revenue Share by Manufacturers (2014-2019)
- 3.3 Sodium Valproate Price by Manufacturers
- 3.4 Sodium Valproate Manufacturing Base Distribution, Product Types
- 3.4.1 Sodium Valproate Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Sodium Valproate Product Type
- 3.4.3 Date of International Manufacturers Enter into Sodium Valproate Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Sodium Valproate Sales by Product
- 4.2 Global Sodium Valproate Revenue by Product
- 4.3 Sodium Valproate Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Sodium Valproate Breakdown Data by End User
6 North America
- 6.1 North America Sodium Valproate by Countries
- 6.1.1 North America Sodium Valproate Sales by Countries
- 6.1.2 North America Sodium Valproate Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Sodium Valproate by Product
- 6.3 North America Sodium Valproate by End User
7 Europe
- 7.1 Europe Sodium Valproate by Countries
- 7.1.1 Europe Sodium Valproate Sales by Countries
- 7.1.2 Europe Sodium Valproate Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Sodium Valproate by Product
- 7.3 Europe Sodium Valproate by End User
8 Asia Pacific
- 8.1 Asia Pacific Sodium Valproate by Countries
- 8.1.1 Asia Pacific Sodium Valproate Sales by Countries
- 8.1.2 Asia Pacific Sodium Valproate Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Sodium Valproate by Product
- 8.3 Asia Pacific Sodium Valproate by End User
9 Central & South America
- 9.1 Central & South America Sodium Valproate by Countries
- 9.1.1 Central & South America Sodium Valproate Sales by Countries
- 9.1.2 Central & South America Sodium Valproate Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Sodium Valproate by Product
- 9.3 Central & South America Sodium Valproate by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Sodium Valproate by Countries
- 10.1.1 Middle East and Africa Sodium Valproate Sales by Countries
- 10.1.2 Middle East and Africa Sodium Valproate Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Sodium Valproate by Product
- 10.3 Middle East and Africa Sodium Valproate by End User
11 Company Profiles
- 11.1 sanofi-aventis
- 11.1.1 sanofi-aventis Company Details
- 11.1.2 Company Business Overview
- 11.1.3 sanofi-aventis Sodium Valproate Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 sanofi-aventis Sodium Valproate Products Offered
- 11.1.5 sanofi-aventis Recent Development
- 11.2 AbbVie
- 11.2.1 AbbVie Company Details
- 11.2.2 Company Business Overview
- 11.2.3 AbbVie Sodium Valproate Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 AbbVie Sodium Valproate Products Offered
- 11.2.5 AbbVie Recent Development
- 11.3 Athenex
- 11.3.1 Athenex Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Athenex Sodium Valproate Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Athenex Sodium Valproate Products Offered
- 11.3.5 Athenex Recent Development
- 11.4 Fresenius Kabi
- 11.4.1 Fresenius Kabi Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Fresenius Kabi Sodium Valproate Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Fresenius Kabi Sodium Valproate Products Offered
- 11.4.5 Fresenius Kabi Recent Development
- 11.5 Hikma Farmaceutica
- 11.5.1 Hikma Farmaceutica Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Hikma Farmaceutica Sodium Valproate Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Hikma Farmaceutica Sodium Valproate Products Offered
- 11.5.5 Hikma Farmaceutica Recent Development
- 11.6 Desitin Pharmaceuticals
- 11.6.1 Desitin Pharmaceuticals Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Desitin Pharmaceuticals Sodium Valproate Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Desitin Pharmaceuticals Sodium Valproate Products Offered
- 11.6.5 Desitin Pharmaceuticals Recent Development
- 11.7 Wockhardt
- 11.7.1 Wockhardt Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Wockhardt Sodium Valproate Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Wockhardt Sodium Valproate Products Offered
- 11.7.5 Wockhardt Recent Development
- 11.8 Zentiva
- 11.8.1 Zentiva Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Zentiva Sodium Valproate Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Zentiva Sodium Valproate Products Offered
- 11.8.5 Zentiva Recent Development
12 Future Forecast
- 12.1 Sodium Valproate Market Forecast by Regions
- 12.1.1 Global Sodium Valproate Sales Forecast by Regions 2019-2025
- 12.1.2 Global Sodium Valproate Revenue Forecast by Regions 2019-2025
- 12.2 Sodium Valproate Market Forecast by Product
- 12.2.1 Global Sodium Valproate Sales Forecast by Product 2019-2025
- 12.2.2 Global Sodium Valproate Revenue Forecast by Product 2019-2025
- 12.3 Sodium Valproate Market Forecast by End User
- 12.4 North America Sodium Valproate Forecast
- 12.5 Europe Sodium Valproate Forecast
- 12.6 Asia Pacific Sodium Valproate Forecast
- 12.7 Central & South America Sodium Valproate Forecast
- 12.8 Middle East and Africa Sodium Valproate Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Sodium Valproate Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Sodium Valproate. Industry analysis & Market Report on Sodium Valproate is a syndicated market report, published as Global Sodium Valproate Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Sodium Valproate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
